Literature DB >> 29449311

Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis.

Tomohide Yamada1, Nobuhiro Shojima2, Hisashi Noma3, Toshimasa Yamauchi2, Takashi Kadowaki2.   

Abstract

Entities:  

Year:  2018        PMID： 29449311     DOI： 10.2337/dc17-2095

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  2 in total

Review 1.  Leveraging the Gut to Treat Metabolic Disease.

Authors:  Ruth E Gimeno; Daniel A Briere; Randy J Seeley
Journal:  Cell Metab       Date:  2020-03-17       Impact factor: 27.287

2.  Efficacy and Patient Satisfaction of Dipeptidyl Peptidase-4 Inhibitor After Switching From Once-Daily DPP-4 Inhibitor to Once-Weekly Regimen.

Authors:  Katsunori Suzuki; Kazuki Hasegawa; Mio Watanabe
Journal:  J Clin Med Res       Date:  2018-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.